Tiffany Tse

Tiffany Tse is a Scientist at Star Therapeutics since February 2022, previously serving as an Associate Scientist at Ambys Medicines from June 2020 to January 2022, and at CytomX Therapeutics from September 2017 to May 2020 within the Cancer Immunology group, where evaluation and development of new Probody targets and platforms were primary focuses. Prior experience includes a Senior Research Associate role at Cell Design Labs, contributing to CAR-T cell therapy technology, and positions at Fluidigm Corporation and DVS Sciences, where development of reagents for mass cytometry was emphasized. Early research experience includes work at Stanford University School of Medicine studying influenza vaccine efficacy and at the University of California Davis investigating calcium signaling in neutrophil recruitment. Tiffany holds a B.S. in Biomedical Engineering from the University of California, Davis.